retatrutide cancer Demand for Unapproved Weight-Loss Drug Surges on Social Media STUDY: Novel “Triagonist” Retatrutide Resolved

December 03, 2025 By Leigh Farmer Glucagon-like peptide-1 receptor agonists, better known as GLP-1s, are naturally made in our intestines after we eat a meal

Suryadevara V, Roy A, Sahoo J, et al

Tirzepatide takes this a step further as a dual agonist, influencing two hormone receptors: GLP-1 and GIP

Safety Bridging : If the blood levels are the same, you can argue that the RLDs extensive safety data (cardiovascular outcomes, etc.) also applies to your product

[16] [3] Patients taking insulin or sulfonylureas alongside any GLP-1class agent should be aware of an increased risk of hypoglycaemia (low blood sugar)

Ortiz-Pujols agrees, noting that finding the right medication and dosage is likely just a matter of trial and error